Transactions
11
Insider / BECTON DICKINSON & CO
Polen Thomas E Jr
Chairman, CEO and President at BECTON DICKINSON & CO
- Company
- BECTON DICKINSON & CO
- Ticker
- BDX
- First filing on record
- December 1, 2025
- Latest trade on record
- August 13, 2026
- SEC filings
- EDGAR ↗
Polen Thomas E Jr, Chairman, CEO and President at BECTON DICKINSON & CO, has disclosed 11 transactions in BDX since December 1, 2025: 0 purchases (0 open-market buys) and 5 sales, worth about $20.7M at the reported prices. The latest was filed August 14, 2026, 1 day after the trade; 3 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
5
Avg. disclosure lag
2.5d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Polen Thomas E Jr made no purchases and 5 sales worth $11M, plus 6 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Polen Thomas E Jr has traded 1 stock on record; the largest by dollars is BDX.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 4 | 126,974 | $9.8M |
| A | Grant or award | 2 | 188,102 | — |
| D | Sale back to the company | 2 | 56,571 | $9.8M |
| S | Open-market sale | 2 | 6,916 | $1.2M |
| F | Shares withheld for tax | 1 | 17,421 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 8 | 0 | 4 · $11.0M |
| 2025 | 3 | 0 | 1 · $0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| BDX | Option / conversion M | August 13, 2026 | August 14, 2026 | 1d | 43,278 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| BDX | Sell S | August 13, 2026 | August 14, 2026 | 1d | 4,152 | $185 | $768K | 10b5-1 plan | Form 4 ↗ | |
| BDX | Sell D | August 13, 2026 | August 14, 2026 | 1d | 39,126 | $185 | $7.2M | 10b5-1 plan | Form 4 ↗ | |
| BDX | Option / conversion M | August 13, 2026 | August 14, 2026 | 1d | 43,278 | $167 | $7.2M | 10b5-1 plan | Form 4 ↗ | |
| BDX | Option / conversion M | June 1, 2026 | June 3, 2026 | 2d | 20,209 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| BDX | Sell S | June 1, 2026 | June 3, 2026 | 2d | 2,764 | $146 | $405K | 10b5-1 plan | Form 4 ↗ | |
| BDX | Sell D | June 1, 2026 | June 3, 2026 | 2d | 17,445 | $146 | $2.5M | 10b5-1 plan | Form 4 ↗ | |
| BDX | Option / conversion M | June 1, 2026 | June 3, 2026 | 2d | 20,209 | $126 | $2.5M | 10b5-1 plan | Form 4 ↗ | |
| BDX | Other A | November 26, 2025 | December 1, 2025 | 5d | 165,581 | — | — | latederivative | Form 4 ↗ | |
| BDX | Sell F | November 26, 2025 | December 1, 2025 | 5d | 17,421 | — | — | late | Form 4 ↗ | |
| BDX | Other A | November 26, 2025 | December 1, 2025 | 5d | 22,521 | — | — | late | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| August 14, 2026 | Form 4 | 0001628280-26-057166 | 4 | published | EDGAR ↗ |
| June 3, 2026 | Form 4 | 0001628280-26-040095 | 4 | published | EDGAR ↗ |
| December 1, 2025 | Form 4 | 0001628280-25-054339 | 3 | published | EDGAR ↗ |
Other insiders at BECTON DICKINSON & CO
- Feld Michael EVP, Chief Revenue Officer 15 rows
- Garrison Michael David EVP & Pres Med.Essntl&BioPharm 11 rows
- Huffines Robert Luther Director 11 rows
- Henderson Jeffrey William Director 7 rows
- DelOrefice Christopher Chief Financial Officer 6 rows
- Brown William M Director 5 rows
- Byington Carrie L Director 5 rows
- Minnix Lanesha EVP and General Counsel 5 rows
- SCOTT BERTRAM L Director 5 rows
- Goette Roland EVP and President, EMEA 4 rows
Everyone on file, with contracts and lobbying under the company's name: BECTON DICKINSON & CO.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 11 | December 1, 2025 | August 14, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.